trospium chloride

PURPOSE An extended release formulation of trospium chloride was recently developed for the once daily treatment of overactive… (More)

OBJECTIVES To study the efficacy and safety of trospium chloride in treating overactive bladder. Trospium chloride is an… (More)

PURPOSE We assessed the efficacy and most appropriate dosage of trospium chloride (TCl) for managing bladder instability in… (More)

Our objectives were to ascertain the tolerability and efficacy of trospium chloride in doses of 20 mg twice daily for long-term… (More)

OBJECTIVE Central nervous effects of oral anticholinergics may limit the success of incontinence therapy and patient compliance… (More)

OBJECTIVES To assess the efficacy and safety of trospium chloride (TCl, 20 mg twice daily) in the treatment of detrusor… (More)

OBJECTIVE To compare trospium chloride (TCl), a quaternary ammonium derivative with atropine-like effects and predominantly… (More)

Trospium chloride and oxybutynin are two antimuscarinergic agents used in the treatment of unstable bladder, urge incontinence… (More)

In a multicentre placebo-controlled double-blind study 61 patients with spinal cord injuries and detrusor hyperreflexia were… (More)

For the quaternary compound trospium chloride (Spasmex) which is used as an anticholinergic agent a new sensitive assay method… (More)